According to variations in the expressions of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancer were defined as four major intrinsic molecular subtypes: luminal A, luminal B, HER2-positive and triple-negative breast cancer (TNBC) (Sorlie et al., 2001). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.